Topical Spray
Products Forms
Liposomal Topical Spray
Products will Available Soon.
Key Technology Benefits
- Advanced Local Delivery
- Liposomal topical sprays that combine phospholipid-based encapsulation with convenient spray administration for localized pharmaceutical delivery.
- The liposomal carrier can enhance drug dispersion, protect sensitive actives, and support controlled interaction with the skin surface.
- Formulation Development
- Based on the API’s physicochemical properties, therapeutic indication, dose, and target skin site, multiple prototype formulations are screened.
- Key variables include phospholipid composition, lipid-to-drug ratio, vesicle characteristics, solvent system, penetration enhancers, viscosity, pH, and spray-ability.
- Formulations can be optimized for aqueous or hydroalcoholic systems according to API compatibility and product requirements.
- The Science of Liposomal Topical Spray
- Localized Pain Management: Liposomal encapsulation supports efficient deposition of the active ingredient at the application site for targeted topical action.
- Anti-Inflammatory Effect: The formulation can facilitate localized delivery of suitable APIs to help address inflammation, swelling, and discomfort.
- Skin Delivery Optimization
- The formulation is designed to promote uniform deposition and effective topical delivery while minimizing unnecessary systemic exposure.
- Liposomal encapsulation may improve wetting, residence time, and interaction with the stratum corneum, depending on the active ingredient and vesicle design.
- Spray System Selection
- Appropriate pump-spray or aerosol technology is evaluated for dose uniformity, plume characteristics, droplet size, priming, actuation force, and container compatibility.
- Device selection is aligned with formulation rheology and intended application area to achieve consistent dosing.
- Analytical & Performance Evaluation
- Development includes particle size, PDI, zeta potential, entrapment efficiency, pH, viscosity, assay, impurities, and physical stability assessment.
- In-vitro release and ex-vivo skin permeation studies can be performed to characterize drug release, deposition, and penetration behaviour of the skin.
